More on Portola Pharma Q2 results

Portola Pharmaceuticals (PTLA -0.7%) Q2 results: Revenues: $2.4M (-7.7%); Operating Expenses: $33.9M (+38.4%); Operating Loss: ($31.5M) (-43.8%); Net Loss: ($31.4M) (-45.4%); Loss Per Share: ($0.76) (+48.3%); Quick Assets: $285.9M (-10.4%).

No guidance given.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs